Viewing Study NCT04946968

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:36 PM
Ignite Modification Date: 2026-02-02 @ 3:17 PM
Study NCT ID: NCT04946968
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-11
First Post: 2021-06-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers
Sponsor: National Cancer Centre, Singapore
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumours View
None Non-small Cell Lung Cancer View
None Head and Neck Squamous Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None EGFR-driven advanced solid tumours View
None Low EGFR-AS1 lncRNA expression View
None Novel emerging biomarker View